Skip to main content
. 2010 Mar;12(2):84–93. doi: 10.1111/j.1477-2574.2009.00127.x

Table 1.

Clinical, operative and pathological characteristics with respect to tumour burden

Prognostic factors Tumour burden
P-value
Low (n= 154) Moderate (n= 262) High (n= 289)
Age (years)
<65 74 (48.1%) 140 (53.4%) 148 (51.2%) 0.569
≥65 80 (51.9%) 122 (46.6%) 141 (48.8%)
Gender
Male 92 (59.7%) 167 (63.7%) 187 (64.7%) 0.575
Female 62 (40.3%) 95 (36.3%) 102 (35.3%)
Presentation
Synchronous 60 (39.0%) 99 (37.8%) 139 (48.1%) 0.164
Metachronous 94 (61.0%) 163 (62.2%) 150 (51.9%)
IRT*
Yes 16 (14.0%) 33 (16.3%) 67 (29.5%) <0.001
No 98 (86.0%) 169 (83.7%) 160 (70.5%)
Extent of resection
Less than hemi-hepatectomy 102 (66.2%) 100 (38.2%) 61 (21.1%) <0.001
Hemi-hepatectomy or more 52 (33.8%) 162 (61.8%) 228 (78.9%)
Blood transfusion 32 (20.8%) 61 (23.3%) 56 (19.4%) 0.529
Morbidity 59 (38.3%) 102 (38.9%) 130 (45.0%) 0.248
Resection margin
R1 (Involved) 35 (22.7%) 83 (31.7%) 140 (48.4%) <0.001
R0 (≥1 mm) 119 (77.3%) 179 (68.3%) 149 (51.6%)
*

IRT was available in 543 (77.0%) patients, with 114 (74.0%), 202 (77.1%) and 227 (78.5%) patients, respectively, in the low, moderate and high tumour burden groups.